BMT CTN Protocol 0803

High Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients

Below are protocol-related documents, which may be periodically updated.

            Protocol Chair: Joseph Alvarnas, MD

            Protocol Co-Chair: Richard Ambinder, MD (410-955-8839)

            Protocol Officer: Willis Navarro

            Protocol Coordinator: Samantha Wilkins (301-251-1161)

            Medical Monitor: Bipin Savani


This study reached its target patient accrual on May 15, 2013 and is now closed to new enrollment.